|
CAP2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.210300E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.602600E-04 |
| Normal-vs-Stage2 |
6.023700E-02 |
| Normal-vs-Stage3 |
6.284700E-03 |
| Normal-vs-Stage4 |
2.818000E-02 |
| Stage1-vs-Stage2 |
9.782800E-01 |
| Stage1-vs-Stage3 |
9.350400E-01 |
| Stage1-vs-Stage4 |
9.736000E-01 |
| Stage2-vs-Stage3 |
9.777600E-01 |
| Stage2-vs-Stage4 |
9.975400E-01 |
| Stage3-vs-Stage4 |
9.784000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.777800E-04 |
| Normal-vs-AfricanAmerican |
9.597700E-02 |
| Normal-vs-Asian |
3.579200E-01 |
| Caucasian-vs-AfricanAmerican |
7.449000E-01 |
| Caucasian-vs-Asian |
7.815800E-01 |
| AfricanAmerican-vs-Asian |
8.961200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.437400E-03 |
| Normal-vs-Female |
8.19790000000653E-05 |
| Male-vs-Female |
9.818400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.356980E-01 |
| Normal-vs-Age(41-60Yrs) |
1.224860E-04 |
| Normal-vs-Age(61-80Yrs) |
9.077900E-03 |
| Normal-vs-Age(81-100Yrs) |
1.827190E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.608600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.302000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.105000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.258840E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.786400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.284400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.868300E-02 |
| Normal-vs-Grade 2 |
8.169700E-04 |
| Normal-vs-Grade 3 |
1.85991999999136E-05 |
| Normal-vs-Grade 4 |
6.229200E-01 |
| Grade 1-vs-Grade 2 |
4.790000E-01 |
| Grade 1-vs-Grade 3 |
7.483400E-01 |
| Grade 1-vs-Grade 4 |
2.169700E-02 |
| Grade 2-vs-Grade 3 |
2.599000E-01 |
| Grade 2-vs-Grade 4 |
2.075800E-03 |
| Grade 3-vs-Grade 4 |
1.000340E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.44319947290728E-10 |
| Normal-vs-ccB subtype |
4.345200E-01 |
| ccA subtype-vs-ccB subtype |
1.98330000200642E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.189700E-04 |
| Normal-vs-N1 |
4.014200E-01 |
| N0-vs-N1 |
6.169000E-01 |
|
|
